Neurocrine Biosciences
NBIX
NBIX
526 hedge funds and large institutions have $10.7B invested in Neurocrine Biosciences in 2022 Q4 according to their latest regulatory filings, with 107 funds opening new positions, 194 increasing their positions, 169 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
526
Holders Change
+62
Holders Change %
+13.36%
% of All Funds
8.49%
Holding in Top 10
9
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-25%
% of All Funds
0.15%
New
107
Increased
194
Reduced
169
Closed
39
Calls
$38M
Puts
$3.89M
Net Calls
+$34.1M
Net Calls Change
+$26.4M
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$245M |
| 2 |
2
BlackRock
New York
|
$1.51B |
| 3 |
3
Invesco
Atlanta,
Georgia
|
$170M |
| 4 |
4
Fidelity Investments
Boston,
Massachusetts
|
$93.9M |
| 5 |
5
Wellington Management Group
Boston,
Massachusetts
|
$144M |
